Authors


Jithin Yohannan, MD, MPH

Latest:

AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH

An AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma management, especially for nonspecialists.


Peter Hnik, MD, MHSc

Latest:

Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucoma

A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.


Akihiro Kakehashi, MD, PhD

Latest:

The truth about invisible posterior vitreous structures

The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.


Ashtyn Zapletal

Latest:

Pigskins and perception: How neuro-ophthalmology influences NFL referees

Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.


Amanda Nanasy, OD

Latest:

Treating traumatic brain injury neuro-optometrically

Physicians note the impact of prism lenses can be life-changing for patients.


Allen C. Ho, MD, FACS, FASRS

Latest:

MCO-010 optogenetic gene therapy for severe vision loss in Stargardt disease

The treatment option can have a positive impact on quality of life for patients.


Brandon Kingrey, MD

Latest:

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.


Jacob A. Rogers

Latest:

Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulas

Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.


Jella An, MD

Latest:

Netarsudil provides IOP lowering in goniotomy treated eyes

The unique MOA may deliver a synergistic effect when prescribed post-surgically.


Jeremiah Brown Jr, MD

Latest:

Shifting paradigm in GA management means focusing attention on imaging

Ophthalmologists can use OCT to find the early signs of disease


Andrew R. Harrison, MD

Latest:

Advancement in TED treatment is a bright spot

FDA approval of teprotumumab as therapeutic offers hope for patients.


Gerald J. Roper, MD

Latest:

Protecting cataract patients and their surgeons' practices

Maximizing refractive surgery is key to ensuring prosperous future


Steven A. Greenstein, MD

Latest:

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.


Colin R. Green, PhD, DSc

Latest:

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.


Bonnie An Henderson, MD

Latest:

ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery

AI’s use in diagnostic tools, surgical guidance, and its ethical considerations in ophthalmology are transforming the field


Vicente Diaz, MD

Latest:

Tuning out anxiety: the role of music in cataract surgery

From easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.



Sydney M Crago

Latest:

Cencora to support US launch of Neurotech’s cell therapy, ENCELTO

Neurotech partners with Cencora for the U.S. launch of ENCELTO, the first FDA-approved treatment for MacTel, enhancing patient access and support.


Brittany Simmons, MD

Latest:

Envision Summit 2025: Advice on treating periorbital eye injuries

At the Envision Summit 2025 in San Juan, Puerto Rico, Brittany Simmons, MD, discussed periorbital injuries and how they can affect the soft tissue and bones around the eye and gives insight into how clinicians should best go about treating it.


Abby Markward, MBA

Latest:

Sneak preview: the ASCRS Foundation's blockbuster plans kick off in Los Angeles

Abby Markward, MBA, executive director of the ASCRS Foundation and ASOA, discusses the foundation's global initiatives and the ASCRS Party for a Purpose.


Majda Hadziahmetovic, MD

Latest:

Envision Summit 2025: Deep learning models of neovascular AMD

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.


S.K. Steven Houston III, MD, FASRS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Nancy Holekamp, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Marco Mura, MD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Karl Stonecipher, MD

Latest:

Final Pearls on Managing Dry Eye Patients With Comorbidities

Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.


Mark T. Dunbar, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Samir N. Patel, MD

Latest:

Focusing on postinjection endophthalmitis

Systemic immunosuppression may prevent devastating complication in patients.



Victor H. Gonzalez, MD

Latest:

Seize underutilized opportunity to treat glaucoma during vitrectomy

Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.


Marta Ibarz Barberá, MD

Latest:

Benefits of topography-guided treatments for irregular corneas

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.

© 2025 MJH Life Sciences

All rights reserved.